Publications by authors named "Enyu Imai"

Claim this Profile
A
A meta-analysis of albuminuria as a surrogate endpoint for kidney failure.
Hiddo J L Heerspink, Willem H Collier, Juhi Chaudhari, Shiyuan Miao, Hocine Tighiouart, Enyu Imai

Nat Med· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Dapagliflozin for the Treatment of Collagenofibrotic Glomerulopathy.
Enyu Imai, Atsuhiro Imai, Masaaki Izumi, Jun Nakazawa, Hideki Fujii

Intern Med· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinical Implications of Slope of GFR in Clinical Trials of CKD Progression.
Tom Greene, Willem Collier, Benjamin Haaland, Chong Zhang, Sunil V Badve, Enyu Imai

Clin J Am Soc Nephrol· May 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The comparison of four hypoxia-inducible factor prolyl hydroxylase inhibitors on drug potency and cost for treatment in patients with renal anemia.
Enyu Imai, Atsuhiro Imai

Clin Exp Nephrol· November 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Association between Acute Declines in eGFR during Renin-Angiotensin System Inhibition and Risk of Adverse Outcomes.
Elaine Ku, Hocine Tighiouart, Charles E McCulloch, Lesley A Inker, Ogechi M Adingwupu, Enyu Imai

J Am Soc Nephrol· October 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A meta-analysis of randomized controlled clinical trials for implications of acute treatment effects on glomerular filtration rate for long-term kidney protection.
Hiddo J L Heerspink, Devin Eddington, Juhi Chaudhari, Raymond Estacio, Enyu Imai

Kidney Int· October 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Home blood pressure-lowering effect of a non-steroidal mineralocorticoid receptor blocker, esaxerenone, versus trichlormethiazide for uncontrolled hypertension: the EXCITE-HT randomized controlled study.
Kazuomi Kario, Hiroyuki Ohbayashi, Masami Hashimoto, Naoki Itabashi, Mitsutoshi Kato, Enyu Imai

Hypertens Res· September 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The Comparison between Vadadustat and Daprodustat Regarding Dose, Cost, and Safety of Treatment for Renal Anemia in Non-dialysis Patients with Chronic Kidney Diseases.
Enyu Imai, Atsuhiro Imai

Intern Med· July 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Angiotensin-Converting Enzyme Inhibitors or Angiotensin-Receptor Blockers for Advanced Chronic Kidney Disease : A Systematic Review and Retrospective Individual Participant-Level Meta-analysis of Clinical Trials.
Elaine Ku, Lesley A Inker, Hocine Tighiouart, Charles E McCulloch, Ogechi M Adingwupu, Enyu Imai

Ann Intern Med· July 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Higher hemoglobin levels using darbepoetin alfa and kidney outcomes in advanced chronic kidney disease without diabetes: a prespecified secondary analysis of the PREDICT trial.
Shoichi Maruyama, Shimon Kurasawa, Terumasa Hayashi, Masaomi Nangaku, Ichiei Narita, Enyu Imai

Clin Exp Nephrol· September 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A meta-analysis of GFR slope as a surrogate endpoint for kidney failure.
Lesley A Inker, Willem Collier, Tom Greene, Shiyuan Miao, Juhi Chaudhari, Enyu Imai

Nat Med· July 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Change in Albuminuria and GFR Slope as Joint Surrogate End Points for Kidney Failure: Implications for Phase 2 Clinical Trials in CKD.
Hiddo J L Heerspink, Lesley A Inker, Hocine Tighiouart, Willem H Collier, Benjamin Haaland, Enyu Imai

J Am Soc Nephrol· June 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Evaluation of Variation in the Performance of GFR Slope as a Surrogate End Point for Kidney Failure in Clinical Trials that Differ by Severity of CKD.
Willem Collier, Lesley A Inker, Benjamin Haaland, Gerald B Appel, Sunil V Badve, Enyu Imai

Clin J Am Soc Nephrol· February 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Deep learning analysis of clinical course of primary nephrotic syndrome: Japan Nephrotic Syndrome Cohort Study (JNSCS).
Tomonori Kimura, Ryohei Yamamoto, Mitsuaki Yoshino, Ryuichi Sakate, Enyu Imai

Clin Exp Nephrol· December 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Hyporesponsiveness to erythropoiesis-stimulating agent in non-dialysis-dependent CKD patients: The BRIGHTEN study.
Ichiei Narita, Terumasa Hayashi, Shoichi Maruyama, Takao Masaki, Masaomi Nangaku, Enyu Imai

PLoS One· December 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Acute Kidney Injury and Remission of Proteinuria in Minimal Change Disease.
Ryohei Yamamoto, Enyu Imai, Shoichi Maruyama, Hitoshi Yokoyama, Hitoshi Sugiyama

Kidney Int Rep· October 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effect of Pemafibrate on Serum Creatinine in Patients with Chronic Kidney Disease.
Enyu Imai, Atsuhiro Imai

JMA J· July 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Predictors of early remission of proteinuria in adult patients with minimal change disease: a retrospective cohort study.
Ryohei Yamamoto, Enyu Imai, Shoichi Maruyama, Hitoshi Yokoyama, Hitoshi Sugiyama

Sci Rep· June 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Time to remission of proteinuria and incidence of relapse in patients with steroid-sensitive minimal change disease and focal segmental glomerulosclerosis: the Japan Nephrotic Syndrome Cohort Study.
Ryohei Yamamoto, Enyu Imai, Shoichi Maruyama, Hitoshi Yokoyama, Hitoshi Sugiyama

J Nephrol· May 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A Comparative Study of Serum Phosphate and Related Parameters in Chronic Kidney Disease between the USA and Japan.
Naohiko Fujii, Takayuki Hamano, Jesse Y Hsu, Enyu Imai, Tadao Akizawa

Am J Nephrol· April 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Acute Treatment Effects on GFR in Randomized Clinical Trials of Kidney Disease Progression.
Brendon L Neuen, Hocine Tighiouart, Hiddo J L Heerspink, Edward F Vonesh, Juhi Chaudhari, Enyu Imai

J Am Soc Nephrol· February 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Initial responsiveness to darbepoetin alfa and its contributing factors in non-dialysis chronic kidney disease patients in Japan.
Terumasa Hayashi, Hideki Kato, Kenichiro Tanabe, Masaomi Nangaku, Hideki Hirakata, Enyu Imai

Clin Exp Nephrol· February 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Better remission rates in elderly Japanese patients with primary membranous nephropathy in nationwide real-world practice: The Japan Nephrotic Syndrome Cohort Study (JNSCS).
Hitoshi Yokoyama, Ryohei Yamamoto, Enyu Imai, Shoichi Maruyama, Hitoshi Sugiyama

Clin Exp Nephrol· October 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Incidence of remission and relapse of proteinuria, end-stage kidney disease, mortality, and major outcomes in primary nephrotic syndrome: the Japan Nephrotic Syndrome Cohort Study (JNSCS).
Ryohei Yamamoto, Enyu Imai, Shoichi Maruyama, Hitoshi Yokoyama, Hitoshi Sugiyama

Clin Exp Nephrol· June 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Darbepoetin Alfa in Patients with Advanced CKD without Diabetes: Randomized, Controlled Trial.
Terumasa Hayashi, Shoichi Maruyama, Masaomi Nangaku, Ichiei Narita, Hideki Hirakata, Enyu Imai

Clin J Am Soc Nephrol· May 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis